Apple’s recent acquisition of health startup Gliimpse is the latest in a long series of strategic moves by the Cupertino, Calif.-based company to capture mindshare and market share in a healthcare industry increasingly reliant on data.

News of the tech giant’s purchase of Gliimpse—a personal health record aggregator—did not come from Apple, which does not comment on its acquisitions or the strategy behind them. Reports of the acquisition first surfaced in Fast Company, a business magazine that covers the technology industry. Apple and Gliimpse executives did not immediately respond to requests for comment.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access